研究室員 (2名) を募集させていただきます。(日本語版は下にあります）

2 research positions available (pathologist, computational biologist, bioinformatician; other experts can be considered)

With my new NCI R35 Outstanding Investigator Award (OIA) grant (2015-2022), I am seeking candidates for 2 positions (pathologist, computational biologist, and/or bioinformatician) in my laboratory at Dana-Farber Cancer Institute (DFCI), Harvard T.H. Chan School of Public Health, Brigham and Women's Hospital, and Harvard Medical School, in Boston, MA, USA. Salary can be offered if a candidate has specific skills and expertise. A position may be a research scientist or postdoctoral fellow. This new computational biologist/bioinformatician will also be affiliated with Center for Cancer Computational Biology (CCCB) at DFCI. Candidates in other areas can be considered; other areas include epidemiology, biostatistics, molecular biology, immunology, and clinical medicine. Candidates with funding support will be highly considered, but candidates without funding will also be considered.

My laboratory is The "Molecular Pathological Epidemiology" (MPE) Laboratory, which is a very unique, interdisciplinary multi-institutional laboratory. I established an integrative science of MPE (Ogino et al. J Natl Cancer Inst 2010; Ogino et al. Nat Rev Clin Oncol 2011; Field et al. JAMA 2013; etc), and founded the International MPE Meeting Series. I recently hosted The Second International Molecular Pathological Epidemiology (MPE) Meeting on Dec 4-5, 2014, and it concluded as a resounding success. Indeed, I have been making history of MPE. In terms of disease areas, my lab has been working on colorectal cancer, pancreatic cancer, and gastrointestinal neuroendocrine tumors. We have been also working on “immune-MPE”, MPE method development, and integration of MPE and other areas such as causal inference, pharmacoepidemiology, health communication, and comparative effectiveness research. We have been utilizing resources of the Nurses' Health Study (followi!
ng 121,700 women since 1976) and the Health Professionals Follow-up Study (following 51,500 men since 1986). For more information, please visit these links.
http://ogino-mpe-lab.dana-farber.org/
http://www.hsph.harvard.edu/faculty/shuji-ogino/
http://en.wikipedia.org/wiki/Molecular_pathological_epidemiology

Please email me (sogi43@gmail.com) your CV or any inquiry. Please pass this information to anyone who may be interested. Please pardon me if I cannot reply to you because of too many responses or inquiries.

Selected original publications:

R Nishihara et al. NEJM 2013; X Liao et al. NEJM 2012; AT Chan et al. NEJM 2007; E Barry et al. Nature 2013; R Straussman et al. Nature 2012; M Giannakis et al. Nat Genet 2014; K Mima et al. JAMA Oncol 2015; R Nishihara et al. JAMA 2013; T Morikawa et al. JAMA 2011; AT Chan et al. JAMA 2009; S Fink et al. Sci Transl Med 2014; ZR Qian et al. J Clin Oncol 2013; A Kostic et al. Genome Res 2012; M Song et al. JNCI 2015; K Inamura et al. JNCI 2014; P Lochhead et al. JNCI 2013; S Ogino et al. JNCI 2013; A Kuchiba et al. JNCI 2012; M Song et al. Gut 2015; M Yamauchi et al. Gut 2012; K Mima et al. Cancer Immunol Res 2015; etc.

研究室員(2名)の募集

今年の8月より7年間のFundingであるNCIのR35 Outstanding Investigator Award (OIA)Grantの取得に伴い、ボストンにある私のThe Molecular Pathological Epidemiology （MPE) Laboratory分子病理疫学研究室で研究室員（pathologist, computational biologist, bioinformatician）を募集しています。私は日本人として現在唯一のR35 OIA Grant保持者のようです。ポジションとしては常任研究員、ポスドクのいずれかが可能です。経験、能力に応じて給与のサポートも可能です。Computational biologist/bioinformaticianの方はDana-Farber Cancer InstituteのCenter for Cancer Computational Biology (CCCB)にも所属して頂きます。その他、Epidemiology、Biostatistics、Molecular Biology、Immunology, 臨床医学のbackgroundを持つ方も考慮しており、得意な分野・経験を生かしていただきます。プロジェクトは大腸癌、膵臓癌、消化器内分泌腫瘍のMolecular Pathological Epidemiology (MPE、分子病理疫学)、Immuno-MPE（免疫分子病理疫学��）、病気を限定しないＭＰＥの手法の開発、あるいはＭＰＥと他の分野とのあらたな統合分野の設立と多岐にわたります。

この私の分子病理疫学研究室はDana-Farber Cancer Institute, Harvard T.H. Chan School of Public Health, Brigham and Women's Hospital, and Harvard Medical Schoolにわたって存在する常識外れのユニークな研究室です。MPEは私が提唱した学問分野で、その名が示すとおり、分子病理学と疫学の統合という誕生して間もない新しい学問分野です（S Ogino et al. JNCI 2010; S Ogino et al. Nat Rev Clin Oncol 2011; A Field et al. JAMA 2013; etc)。私は2014年12月に第2回国際分子病理疫学学会を主催し、成功させ、すでに第３回国際分子病理疫学学会を2016年5月に計画中です。このように分子病理疫学の歴史を作っています。

私のラボでは大規模な前向き疫学コホートを使って大腸癌と膵臓癌の様々な分子異常の疫学的病因を研究しています。ハーバード大学公衆衛生大学院とBrigham and Women’s Hospitalではこれまで当初は健康な12万人の女性を39年（Nurses' Health Study、http://www.channing.harvard.edu/nhs/）、5万人の男性を29年（Health Professionals Follow-up Study、http://www.hsph.harvard.edu/hpfs/）追跡して、病気の発生を疫学的に研究してきました。我々のMPE　Researchの強みは最近のさまざまな論文で示されています(上に主要な論文を列挙しました)。分子病理疫学と私の研究室についてはこれらのサイトをご覧ください。
http://ogino-mpe-lab.dana-farber.org/
http://www.hsph.harvard.edu/faculty/shuji-ogino/
http://en.wikipedia.org/wiki/Molecular_pathological_epidemiology

興味のある方は（sogi43@gmail.com）宛てにCVをつけて直接連絡をお願いします。興味のありそうな人をご存知の方は、この情報をパスして頂きますと幸いです。お問い合わせや応募が多い場合は返答しきれないことがありますが、ご容赦ください。
荻野周史
Shuji Ogino, MD, PhD, MS
Professor of Pathology and Epidemiology
Harvard Medical School
Brigham and Women’s Hospital
Dana-Farber Cancer Institute
Harvard T.H. Chan School of Public Health